Figure 6.
Working model showing how metformin inhibits TGFβ1 expression and cardiac fibrosis. AngII induces TGFβ1 expression by increasing HNF4α protein expression and binding activity. Metformin targets the HNF4α protein and then inhibits TGFβ1 expression via a process dependent on AMPK activation.